ProCE Banner Activity

Overcoming Treatment Challenges in Patients With Newly Diagnosed AML

Slideset Download
Conference Coverage
Download this slideset from a live ASH symposium reviewing the challenges and treatment options, including recently approved agents, for patients with newly diagnosed acute myeloid leukemia (AML).

Released: December 05, 2018

Expiration: December 04, 2019

No longer available for credit.

Share

Faculty

Gary J. Schiller

Gary J. Schiller, MD

Professor
Division of Hematology/Oncology
Department of Medicine
Director, Hematological Malignancy/Stem Cell Transplantation
David Geffen School of Medicine at UCLA
Los Angeles, California

Provided by

Provided by Postgraduate Institute for Medicine
ProCE Banner

Supporters

This activity is supported by educational grants from

Actinium

Astellas Text

Boston Biomedical

Celgene

Daiichi Sankyo, Inc.

Jazz Pharmaceuticals Inc

Novartis Pharmaceuticals Corporation

Faculty Disclosure

Primary Author

Gary J. Schiller, MD

Professor
Division of Hematology/Oncology
Department of Medicine
Director, Hematological Malignancy/Stem Cell Transplantation
David Geffen School of Medicine at UCLA
Los Angeles, California